1: Evaluate clinical impact of cannabinoids via the endocannabinoid system.
2: Explain current understanding of cannabinoid use and benefit in patients with GI disorders.
3: Educate patients on possible risk and side effects associated with cannabis use.
05/02/2023 - 4:30pm to 5:30pm CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Dr. Jami Kinnucan